Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

4.69USD
2:35pm GMT
Change (% chg)

$0.03 (+0.64%)
Prev Close
$4.66
Open
$4.64
Day's High
$4.69
Day's Low
$4.64
Volume
1,529
Avg. Vol
139,116
52-wk High
$14.62
52-wk Low
$3.60

Chart for

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: --
Market Cap(Mil.): $763.12
Shares Outstanding(Mil.): 93.52
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.00 -- --
ROI: -32.06 8.92 14.45
ROE: -35.60 10.08 15.96

Earnings vs. Estimates